FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34181711000001108: Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Apr 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
103864501000001115 Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
103864601000001116 Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Has VMP Magnesium hydroxide 7.45-8.35% oral suspension BP true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Has specific active ingredient Magnesium hydroxide true Inferred relationship Existential restriction modifier
Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Phillips' Milk of Magnesia 415mg/5ml oral suspension (Omega Pharma Ltd) 200 ml Is a True Magnesium hydroxide 7.45-8.35% oral suspension BP 200 ml Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start